Teradyne

Filing pairs Item 2.02 (results of operations) with Item 9.01 exhibits, indicating Teradyne released quarterly earnings on Apr 28, 2026. PMs should watch SoC/memory ATE demand commentary, HBM tester traction, and any FY guide revision given the AI-driven test capex cycle. Full filing body not analyzed; description inferred from form + item codes.

Quarterly report covering the period ended 2026-03-29, expected to detail semiconductor test and robotics segment revenue, gross margin trends, and updated outlook commentary tied to AI/HBM and SoC test demand. Full filing body not analyzed; description inferred from form + item codes. PMs should watch ATE bookings, China exposure, and any commentary on memory test capex feeding into the KR/TW HBM cycle.

Routine 8-K under Item 5.07 reporting outcomes of shareholder votes (director elections, auditor ratification, say-on-pay) at the annual meeting. Full filing body not analyzed; description inferred from form + item codes. Typically non-market-moving unless a contested vote or material governance pushback surfaces.